David Donnay Rowland, Executive Vice President & Co-Chief Investment Officer, on July 22, 2026, sold 5,000 shares in Travelers Companies (TRV) for $1,858,440. Following the Form 4 filing with the SEC, Rowland has control over a total of 38,485 common shares of the company, with 10,479 shares held directly and 28,006 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/86312/000008631226000156/xslF345X05/form4.xml
Ludmila Smolyansky, Member of 10% Owner Group, on July 22, 2026, sold 100,000 shares in Lifeway Foods (LWAY) for $3,011,400. Following the Form 4 filing with the SEC, Smolyansky has control over a total of 507,207 common shares of the company, with 507,207 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/814586/000168316826005734/xslF345X05/ownership.xml
Martine A Rothblatt, Director, Chairperson & CEO, on July 22, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,040,380. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 748,828 common shares of the company, with 40,513 shares held directly and 708,315 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000110657826000104/xslF345X05/primarydocument.xml
Nancy Koskey Patzwahl, Director, on July 22, 2026, executed a purchase for 25,000 shares in Rhinebeck Bancorp (RBKB) for $298,500. Following the Form 4 filing with the SEC, Patzwahl has control over a total of 27,270 common shares of the company, with 27,270 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1751783/000143774926024324/xslF345X05/rdgdoc.xml